You are here
Treatment with a drug known to cause calculogenesis in the urinary tract
Renal stone disease - Treatment with a drug known to cause calculogenesis in the urinary tract Factor
Last reviewed for CCPS 01 August 1995.
Investigative Documents
Medical Report - Drugs Known to Cause Calculogenesis - Nephrolithiasis [MR9054] Preliminary questions [11106]
11207 the veteran has taken a drug known to play a role in calculogenesis in the urinary tract at some time. the treatment with the drug known to play a role in calculogenesis in the urinary tract continued for at least 90 days. the treatment with the drug known to play a role in calculogenesis in the urinary tract continued for at least 90 days before the clinical onset of the condition under consideration. the veteran's treatment with a drug known to play a role in calculogenesis in the urinary tract for at least 90 days was materially contributed to by treatment of an illness or injury which is identifiable. 11211 — the veteran has established the temporal connection between the identified illness or injury which materially contributed to the treatment with the drug known to play a role in calculogenesis in the urinary tract and VEA service for the clinical onset of the condition under consideration. or
11212 — the veteran has established the causal connection between the identified illness or injury which materially contributed to the treatment with the drug known to play a role in calculogenesis in the urinary tract and VEA service for the clinical onset of the condition under consideration.
11213 — the veteran has established the causal connection between the identified illness or injury which materially contributed to the treatment with the drug known to play a role in calculogenesis in the urinary tract and operational service for the clinical onset of the condition under consideration.
or
11214 — the veteran has established the causal connection between the identified illness or injury which materially contributed to the treatment with the drug known to play a role in calculogenesis in the urinary tract and eligible service for the clinical onset of the condition under consideration.
Clinical onset and operational service [11213]
11215 — the identified illness or injury, which materially contributed to the veteran's treatment with the drug known to play a role in calculogenesis in the urinary tract for at least 90 days, is causally related to operational service.
Clinical onset and eligible service [11214]
11216 — the identified illness or injury, which materially contributed to the veteran's treatment with the drug known to play a role in calculogenesis in the urinary tract for at least 90 days, is causally related to eligible service.